Amyloid-β-stimulated plasminogen activation by tissue-type plasminogen activator results in processing of neuroendocrine factors

Neuroscience

Volumn 131, Issue 4, 2005, Pages 877-886

  Kranenburg, O ^a   Gent, Y Y J ^a   Romijn, E P ^b   Voest, E E ^a   Heck, A J R ^b   Gebbink, M F B G ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

Author keywords

Cross structure; Neurodegeneration; Plasmin

Indexed keywords

AMYLOID BETA PROTEIN; CHROMOGRANIN A; CHROMOGRANIN B; NEUROENDOCRINE PROTEIN VGF; PLASMINOGEN; PROTEIN; SECRETOGRANIN II; TISSUE PLASMINOGEN ACTIVATOR; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ANIMAL CELL; ARTICLE; MOUSE; NEUROTRANSMISSION; NEUROTRANSMITTER RELEASE; NONHUMAN; PLASMINOGEN ACTIVATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN PROCESSING;

EID: 14644392228     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2004.11.044     Document Type: Article

References (56)

1. D. Baranes, D. Lederfein, Y.Y. Huang, M. Chen, C.H. Bailey, E.R. Kandel Tissue plasminogen activator contributes to the late phase of LTP and to synaptic growth in the hippocampal mossy fiber pathway Neuron 21 1998 813 825
2. G. Bissette Neuropeptides and Alzheimer's disease pathology Ann NY Acad Sci 814 1997 17 29
3. P. Carmeliet, L. Schoonjans, L. Kieckens, B. Ream, J. Degen, R. Bronson, R. De Vos, J.J. van den Oord, D. Collen, R.C. Mulligan Physiological consequences of loss of plasminogen activator gene function in mice Nature 368 1994 419 424
4. J.A. Carson, A.J. Turner Beta-amyloid catabolism roles for neprilysin (NEP) and other metallopeptidases? J Neurochem 81 2002 1 8
5. Z.L. Chen, S. Strickland Neuronal death in the hippocampus is promoted by plasmin-catalyzed degradation of laminin Cell 91 1997 917 925
6. W.K. Cullen, J. Wu, R. Anwyl, M.J. Rowan beta-Amyloid produces a delayed NMDA receptor-dependent reduction in synaptic transmission in rat hippocampus Neuroreport 8 1996 87 92
7. K.L. Davis, R.C. Mohs, D.B. Marin, D.P. Purohit, D.P. Perl, M. Lantz, G. Austin, V. Haroutunian Neuropeptide abnormalities in patients with early Alzheimer disease Arch Gen Psychiatry 56 1999 981 987
8. R. D'Hooge, G. Nagels, C.E. Westland, L. Mucke, P.P. De Deyn Spatial learning deficit in mice expressing human 751-amino acid beta-amyloid precursor protein Neuroreport 7 1996 2807 2811
9. C. Exley, O.V. Korchazhkina Plasmin cleaves Abeta42 in vitro and prevents its aggregation into beta-pleated sheet structures Neuroreport 12 2001 2967 2970
10. S.M. Fitzjohn, R.A. Morton, F. Kuenzi, T.W. Rosahl, M. Shearman, H. Lewis, D. Smith, D.S. Reynolds, C.H. Davies, G.L. Collingridge, G.R. Seabrook Age-related impairment of synaptic transmission but normal long-term potentiation in transgenic mice that overexpress the human APP695SWE mutant form of amyloid precursor protein J Neurosci 21 2001 4691 4698
11. A. Gualandris, T.E. Jones, S. Strickland, S.E. Tsirka Membrane depolarization induces calcium-dependent secretion of tissue plasminogen activator J Neurosci 16 1996 2220 2225
12. A.Y. Hsia, E. Masliah, L. McConlogue, G.Q. Yu, G. Tatsuno, K. Hu, D. Kholodenko, R.C. Malenka, R.A. Nicoll, L. Mucke Plaque-independent disruption of neural circuits in Alzheimer's disease mouse models Proc Natl Acad Sci USA 96 1999 3228 3233
13. Y.Y. Huang, M.E. Bach, H.P. Lipp, M. Zhuo, D.P. Wolfer, R.D. Hawkins, L. Schoonjans, E.R. Kandel, J.M. Godfraind, R. Mulligan, D. Collen, P. Carmeliet Mice lacking the gene encoding tissue-type plasminogen activator show a selective interference with late-phase long-term potentiation in both Schaffer collateral and mossy fiber pathways Proc Natl Acad Sci USA 93 1996 8699 8704
14. Y. Ikegaya, S. Matsuura, S. Ueno, A. Baba, M.K. Yamada, N. Nishiyama, N. Matsuki Beta-amyloid enhances glial glutamate uptake activity and attenuates synaptic efficacy J Biol Chem 277 2002 32180 32186
15. A. Itoh, T. Akaike, M. Sokabe, A. Nitta, R. Iida, A. Olariu, K. Yamada, T. Nabeshima Impairments of long-term potentiation in hippocampal slices of beta-amyloid-infused rats Eur J Pharmacol 382 1999 167 175
16. N. Iwata, S. Tsubuki, Y. Takaki, K. Shirotani, B. Lu, N.P. Gerard, C. Gerard, E. Hama, H.J. Lee, T.C. Saido Metabolic regulation of brain Abeta by neprilysin Science 292 2001 1550 1552
17. N. Iwata, S. Tsubuki, Y. Takaki, K. Watanabe, M. Sekiguchi, E. Hosoki, M. Kawashima-Morishima, H.J. Lee, E. Hama, Y. Sekine-Aizawa, T.C. Saido Identification of the major Abeta1-42-degrading catabolic pathway in brain parenchyma suppression leads to biochemical and pathological deposition Nat Med 6 2000 143 150
18. Q. Jiang, L. Taupenot, S.K. Mahata, M. Mahata, D.T. O'Connor, L.A. Miles, R.J. Parmer Proteolytic cleavage of chromogranin A (CgA) by plasmin selective liberation of a specific bioactive CgA fragment that regulates catecholamine release J Biol Chem 276 2001 25022 25029
19. Q. Jiang, S. Yasothornsrikul, L. Taupenot, L.A. Miles, R.J. Parmer The local chromaffin cell plasminogen/plasmin system and the regulation of catecholamine secretion Ann NY Acad Sci 971 2002 445 449
20. I.B. Kingston, M.J. Castro, S. Anderson In vitro stimulation of tissue-type plasminogen activator by Alzheimer amyloid beta-peptide analogues Nat Med 1 1995 138 142
21. O. Kranenburg, B. Bouma, L.M. Kroon-Batenburg, A. Reijerkerk, Y.P. Wu, E.E. Voest, M.F. Gebbink Tissue-type plasminogen activator is a multiligand cross-beta structure receptor Curr Biol 12 2002 1833 1839
22. J. Larson, G. Lynch, D. Games, P. Seubert Alterations in synaptic transmission and long-term potentiation in hippocampal slices from young and aged PDAPP mice Brain Res 840 1999 23 35
23. A. Laslop, S.K. Mahata Neuropeptides and chromogranins session overview Ann NY Acad Sci 971 2002 294 299
24. H. Lassmann, R. Weiler, P. Fischer, C. Bancher, K. Jellinger, E. Floor, W. Danielczyk, F. Seitelberger, H. Winkler Synaptic pathology in Alzheimer's disease immunological data for markers of synaptic and large dense-core vesicles Neuroscience 46 1992 1 8
25. M.D. Ledesma, J.S. Da Silva, K. Crassaerts, A. Delacourte, B. De Strooper, C.G. Dotti Brain plasmin enhances APP alpha-cleavage and Abeta degradation and is reduced in Alzheimer's disease brains EMBO Rep 1 2000 530 535
26. R. Madani, S. Hulo, N. Toni, H. Madani, T. Steimer, D. Muller, J.D. Vassalli Enhanced hippocampal long-term potentiation and learning by increased neuronal expression of tissue-type plasminogen activator in transgenic mice EMBO J 18 1999 3007 3012
27. S.K. Mahata, D.T. O'Connor, M. Mahata, S.H. Yoo, L. Taupenot, H. Wu, B.M. Gill, R.J. Parmer Novel autocrine feedback control of catecholamine release a discrete chromogranin a fragment is a noncompetitive nicotinic cholinergic antagonist J Clin Invest 100 1997 1623 1633
28. J. Marksteiner, W.A. Kaufmann, P. Gurka, C. Humpel Synaptic proteins in Alzheimer's disease J Mol Neurosci 18 2002 53 63
29. J. Marksteiner, T. Lechner, W.A. Kaufmann, P. Gurka, C. Humpel, C. Nowakowski, H. Maier, K.A. Jellinger Distribution of chromogranin B-like immunoreactivity in the human hippocampus and its changes in Alzheimer's disease Acta Neuropathol (Berl) 100 2000 205 212
30. E. Masliah, M. Mallory, L. Hansen, M. Alford, T. Albright, R. DeTeresa, R. Terry, J. Baudier, T. Saitoh Patterns of aberrant sprouting in Alzheimer's disease Neuron 6 1991 729 739
31. A. Matsumoto, K. Itoh, R. Matsumoto A novel carboxypeptidase B that processes native beta-amyloid precursor protein is present in human hippocampus Eur J Neurosci 12 2000 227 238
32. A. Matsumoto, K. Motozaki, T. Seki, R. Sasaki, T. Kawabe Expression of human brain carboxypeptidase B, a possible cleaving enzyme for beta-amyloid precursor protein, in peripheral fluids Neurosci Res 39 2001 313 317
33. D. Moechars, I. Dewachter, K. Lorent, D. Reverse, V. Baekelandt, A. Naidu, I. Tesseur, K. Spittaels, C.V. Haute, F. Checler, E. Godaux, B. Cordell, F. Van Leuven Early phenotypic changes in transgenic mice that overexpress different mutants of amyloid precursor protein in brain J Biol Chem 274 1999 6483 6492
34. D.G. Munoz Chromogranin A-like immunoreactive neurites are major constituents of senile plaques Lab Invest 64 1991 826 832
35. D.G. Munoz, L. Kobylinski, D.D. Henry, D.H. George Chromogranin A-like immunoreactivity in the human brain distribution in bulbar medulla and cerebral cortex Neuroscience 34 1990 533 543
36. Y. Nakagami, K. Abe, N. Nishiyama, N. Matsuki Laminin degradation by plasmin regulates long-term potentiation J Neurosci 20 2000 2003 2010
37. J. Naslund, V. Haroutunian, R. Mohs, K.L. Davis, P. Davies, P. Greengard, J.D. Buxbaum Correlation between elevated levels of amyloid beta-peptide in the brain and cognitive decline JAMA 283 2000 1571 1577
38. W. Nieuwenhuizen Fibrin-mediated plasminogen activation Ann NY Acad Sci 936 2001 237 246
39. W. Nieuwenhuizen Fibrin-mediated plasminogen activation Ann NY Acad Sci 936 2001 237 246
40. R.J. Parmer, M. Mahata, Y. Gong, S.K. Mahata, Q. Jiang, D.T. O'Connor, X.P. Xi, L.A. Miles Processing of chromogranin A by plasmin provides a novel mechanism for regulating catecholamine secretion J Clin Invest 106 2000 907 915
41. R.J. Parmer, M. Mahata, S. Mahata, M.T. Sebald, D.T. O'Connor, L.A. Miles Tissue plasminogen activator (t-PA) is targeted to the regulated secretory pathway catecholamine storage vesicles as a reservoir for the rapid release of t-PA J Biol Chem 272 1997 1976 1982
42. F.J. Salles, S. Strickland Localization and regulation of the tissue plasminogen activator-plasmin system in the hippocampus J Neurosci 22 2002 2125 2134
43. S.R. Salton, G.L. Ferri, S. Hahm, S.E. Snyder, A.J. Wilson, R. Possenti, A. Levi VGF a novel role for this neuronal and neuroendocrine polypeptide in the regulation of energy balance Front Neuroendocrinol 21 2000 199 219
44. N.W. Seeds, M.E. Basham, S.P. Haffke Neuronal migration is retarded in mice lacking the tissue plasminogen activator gene Proc Natl Acad Sci USA 96 1999 14118 14123
45. D.J. Selkoe Toward a comprehensive theory for Alzheimer's disease: hypothesis: Alzheimer's disease is caused by the cerebral accumulation and cytotoxicity of amyloid beta-protein Ann NY Acad Sci 924 2000 17 25
46. J.P. Simon, M.F. Bader, D. Aunis Secretion from chromaffin cells is controlled by chromogranin A-derived peptides Proc Natl Acad Sci USA 85 1988 1712 1716
47. J.P. Simon, M.F. Bader, D. Aunis Proteolytic processing of chromogranin A in cultured chromaffin cells Biochim Biophys Acta 1051 1990 123 130
48. D.H. Small, S.S. Mok, J.C. Bornstein Alzheimer's disease and Abeta toxicity from top to bottom Nat Rev Neurosci 2 2001 595 598
49. L. Taupenot, K.L. Harper, D.T. O'Connor The chromogranin-secretogranin family N Engl J Med 348 2003 1134 1149
50. R.D. Terry Cell death or synaptic loss in Alzheimer disease J Neuropathol Exp Neurol 59 2000 1118 1119
51. H.M. Tucker, M. Kihiko-Ehmann, S. Wright, R.E. Rydel, S. Estus Tissue plasminogen activator requires plasminogen to modulate amyloid-beta neurotoxicity and deposition J Neurochem 75 2000 2172 2177
52. H.M. Tucker, M. Kihiko, J.N. Caldwell, S. Wright, T. Kawarabayashi, D. Price, D. Walker, S. Scheff, J.P. McGillis, R.E. Rydel, S. Estus The plasmin system is induced by and degrades amyloid-beta aggregates J Neurosci 20 2000 3937 3946
53. E. van Anken, E.P. Romijn, C. Maggioni, A. Mezghrani, R. Sitia, I. Braakman, A.J. Heck Sequential waves of functionally related proteins are expressed when B cells prepare for antibody secretion Immunity 18 2003 243 253
54. W.E. Van Nostrand, M. Porter Plasmin cleavage of the amyloid beta-protein alteration of secondary structure and stimulation of tissue plasminogen activator activity Biochemistry 38 1999 11570 11576
55. S. Wnendt, I. Wetzels, W.A. Gunzler Amyloid beta peptides stimulate tissue-type plasminogen activator but not recombinant prourokinase Thromb Res 85 1997 217 224
56. F. Yamaguchi, S.J. Richards, K. Beyreuther, M. Salbaum, G.A. Carlson, S.B. Dunnett Transgenic mice for the amyloid precursor protein 695 isoform have impaired spatial memory Neuroreport 2 1991 781 784